Adimolol

A beta-adrenergic antagonist

Adimolol
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Adimolol is a beta-adrenergic antagonist used in the treatment of hypertension and other cardiovascular conditions. It is a non-selective beta-blocker, meaning it blocks both beta-1 and beta-2 adrenergic receptors.

Pharmacology

Adimolol works by inhibiting the action of epinephrine and norepinephrine on beta-adrenergic receptors, which are part of the sympathetic nervous system. This leads to a decrease in heart rate, cardiac output, and blood pressure.

Mechanism of Action

Adimolol binds to beta-adrenergic receptors on the surface of cells in the heart and vascular smooth muscle. By blocking these receptors, it prevents the usual sympathetic nervous system response, which includes increased heart rate and force of contraction. This results in a reduction of myocardial oxygen demand and helps to manage conditions like angina pectoris and hypertension.

Clinical Uses

Adimolol is primarily used in the management of hypertension and certain types of arrhythmias. It may also be used in the treatment of angina and to prevent myocardial infarction in patients with a history of heart attacks.

Side Effects

Common side effects of adimolol include bradycardia, fatigue, dizziness, and gastrointestinal disturbances. As with other beta-blockers, it may cause bronchospasm in susceptible individuals, such as those with asthma.

Synthesis

The synthesis of adimolol involves the reaction of a phenolic compound with an epoxide, followed by the introduction of an isopropylamino group. The detailed synthetic pathway is illustrated in the accompanying diagram.

Related pages

• Beta blocker
• Hypertension
• Adrenergic receptor
• Cardiovascular disease

Gallery

• 
  Chemical structure of Adimolol
• 
  Synthesis of Adimolol

• 
  Adimolol
• 
  Adimolol synthesis